Miranda Verschraagen

Author

Vrije Universiteit Amsterdam

Also Known As

M Verschraagen, M. VERSCHRAAGEN, Miranda Verschraagen, Verschraagen, M.

Publications

766

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Amsterdam Netherlands Forensic Institute BioNumerik (United States)Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Miranda Verschraagen is an author at Vrije Universiteit Amsterdam specializing in medicine, pharmacology, and metabolomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	529
2	Engineering	1	1	19
3	Health Sciences	1	1	12
4	Natural Sciences	1	1	21
5	Public Health	1	1	58

Miranda Verschraagen

Publications

597

Citations

H-Index

Page 1

	Year	Citations
A case of extreme agitation and death after the use of mephedrone in The Netherlands Klaas J. Lusthof, Roelof Oosting, Ann Maes, Forensic Science International Forensic ToxicologyClub DrugPoisoningDrug OverdoseExtreme Agitation	2011	189
Post-mortem cases involving amphetamine-based drugs in the Netherlands Miranda Verschraagen, Ann Maes, B. Ruiter, Forensic Science International Substance AbusePsychoactive DrugPsychiatryAddictionPost-mortem Cases	2007	68
Simultaneous determination of intact cisplatin and its metabolite monohydrated cisplatin in human plasma Miranda Verschraagen, Kasper van der Born, T.H.Ursula Zwiers, Journal of Chromatography B Intact CisplatinBiochemistryMedicineBioanalysisMass Spectrometry	2002	59
Toxicological Findings in Cases of Sexual Assault in the Netherlands* Ingrid J. Bosman, Miranda Verschraagen, Klaas J. Lusthof Journal of Forensic Sciences Substance UseGynecologySocial SciencesGender StudiesPublic Health	2011	58
BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts Epie Boven, Miranda Verschraagen, T.M. Hulscher, European Journal of Cancer Tumor BiologyOncologyHuman Tumour XenograftsMedicineAnti-cancer Agent	2002	39
Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites Miranda Verschraagen Clinical Pharmacology & Therapeutics	2003	35
The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG Miranda Verschraagen, Marc A. Kedde, Frederick H. Hausheer, Cancer Chemotherapy and Pharmacology Disulfide GssgCytostatic Agent CisplatinMedicinal ChemistryBiochemistryNatural Sciences	2003	21
Quantification of BNP7787 (dimesna) and its metabolite mesna in human plasma and urine by high-performance liquid chromatography with electrochemical detection Miranda Verschraagen, T.H.Ursula Zwiers, Peter E de Koning, Journal of Chromatography B Biomedical Sciences and Applications BiochemistryElectrochemical DetectionMedicineBioanalysisMass Spectrometry	2001	20
Quantification of mesna and total mesna in kidney tissue by high-performance liquid chromatography with electrochemical detection Miranda Verschraagen, Marjolein Bosma, T.H.Ursula Zwiers, Journal of Chromatography B UrologyEngineeringRenal FunctionElectrochemical DetectionBioanalysis	2002	19
Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects Miranda Verschraagen, Epie Boven, Emine Torun, Biochemical Pharmacology Chemoprevention StrategyBiochemistryBiological SitesNew ProtectorMedicine	2004	19

Page 1